(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
The |
Cover |
Apr. 15, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Apr. 15, 2024 |
Entity Registrant Name | LISATA THERAPEUTICS, INC. |
Entity Central Index Key | 0000320017 |
Amendment Flag | false |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-33650 |
Entity Tax Identification Number | 22-2343568 |
Entity Address, Address Line One | 110 Allen Road |
Entity Address, Address Line Two | Second Floor |
Entity Address, City or Town | Basking Ridge |
Entity Address, State or Province | NJ |
Entity Address, Postal Zip Code | 07920 |
City Area Code | 908 |
Local Phone Number | 842-0100 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | LSTA |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
RHY_U=3_ 102P,$% @ @8"16)>*NQS $P( L !?3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/: (7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W M\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'B4?'D78FYJD6:>IK&HP=MX M1PT$G53$WHI"/J:Q8;!EK '$NW2:9;/46PQFN1BUMIS> A(H!"DHV1%[A$O\ MG7 D(GP&LK\,S4-AB. MG8RF2&]B]#V,YU#BG/]3(U45%K"FHO409.B1P74&0ZRQB28)UD-N5G0&[O+H M YMRR"9JZJ8IGJ,.>%,.]D9/)508H'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;* MO8=7LN48Y0]02P,$% @ @8"16"0>FZ*M ^ $ !H !X;"]? M +7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2* M+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\ M7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7 M-_=%KLWC":[?#'!X=/X!4$L#!!0 ( (& D5AED'F2&0$ ,\# 3 M6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/ M&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB M>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9 M/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1 MB5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9 M_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^D &PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 M Q0 ( (& D5A^ROUN9 0 "41 8 " @0T( !X;"]W M;W)K &PO &PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0 M2P$"% ,4 " "!@)%899!YDAD! #/ P $P @ &Q$@ I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" #[$P ! end
:7X<051\J$#DQ \)&6G @$*'S'_" N]-RYF$+;64!R
M' *$H'EX.2NJ2-:0V(S *2"0!Z9';BDR*3$DL+*0 05GDZPOGS$]" XS=SC&
M:CI3,.@Z8>.$L@2!." +@ZG0!IZ0M=IHJC 3*?XM8-!A=2G\_T?&7Q-U3F2<
MP-OW^:*^J=8I8L\XC4AC G!K"3MJ&21*PFOID_$X^>FX^&)X&!4S+E=.(>B<
MF.B7S._S>:X_%96/ZTBTE,)UV^ENQ6R#1R"+0$YQ(KE/DA(Y'1C?6!]&QXP+
MF9-).R=$SNNFM>4?Q56_I7+>1X&'BM5S@Z$FN*]8.[2ER.1R0JPD%
M_SW0Z@/\]D*!T."WC./^"3AS70FR&E%Y:)B%^Q36LKR-L587 _